PROGNOSTIC FACTORS FOR SUCCESSFUL CONVERSION FROM CYCLOSPORINE TO FK-506 - BASED IMMUNOSUPPRESSIVE THERAPY FOR REFRACTORY REJECTION AFTER LIVER-TRANSPLANTATION

被引：0

作者：

KLINTMALM, GBG

GOLDSTEIN, R

GONWA, T

WIESNER, RH

KROM, RAF

SHAW, BW

STRATTA, R

ASCHER, NL

ROBERTS, JW

LAKE, J

BUSUTTIL, RW

MCDIARMID, S

ESQUIVEL, CO

NAKAZATO, P

MARSH, JW

WOODLE, ES

KALAYOGLU, M

DALESSANDRO, AM

PIRSCH, JD

MILLER, C

SCHWARTZ, M

LEWIS, WD

MONACO, AP

JENKINS, RL

EMOND, JC

THISTLETHWAITE, JR

WHITINGTON, PF

STEINMULLER, DR

FITZSIMMONS, WE

LAWRENCE, I

机构：

[1] FUJISAWA PHARMACEUT CO,4 N,3 PKWY N CTR,DEERFIELD,IL 60015

[2] MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905

[3] BAYLOR UNIV,MED CTR,DALLAS,TX

[4] ROCHESTER METHODIST HOSP,ROCHESTER,MN

[5] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO MED CTR,SAN FRANCISCO,CA 94143

[6] UNIV CALIF LOS ANGELES,LOS ANGELES MED CTR,LOS ANGELES,CA 90024

[7] CALIFORNIA PACIFIC MED CTR,SAN FRANCISCO,CA

[8] UNIV WISCONSIN HOSP & CLIN,MADISON,WI

[9] DEACONESS HOSP,BOSTON,MA

[10] UNIV CHICAGO,MED CTR,CHICAGO,IL 60637

[11] UNIV NEBRASKA,MED CTR,OMAHA,NE 68105

[12] BARNES HOSP,ST LOUIS,MO 63110

[13] MT SINAI MED CTR,NEW YORK,NY 10029

来源：

TRANSPLANTATION PROCEEDINGS | 1993年 / 25卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：641 / 643

页数：3

共 50 条

[41] RENAL-FUNCTION AFTER CONVERSION FROM CYCLOSPORINE TO FK-506 IN LIVER-TRANSPLANT PATIENTS
MCCAULEY, J
FUNG, JJ
BROWN, H
DEBALLI, P
JAIN, A
TODO, S
STARZL, TE
TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3148 - 3149
[42] COMPARISON OF SHORT-TERM IMMUNOSUPPRESSIVE THERAPY WITH CYCLOSPORINE AND FK-506 IN SMALL-BOWEL TRANSPLANTATION
LEE, KKW
STANGL, MJ
TODO, S
LANGREHR, JM
HOFFMAN, A
STARZL, TE
SCHRAUT, WH
TRANSPLANTATION PROCEEDINGS, 1990, 22 (06) : 2485 - 2486
[43] ACUTE HEMODYNAMIC-EFFECTS OF FK-506 DURING AND AFTER ORTHOTOPIC LIVER-TRANSPLANTATION
KANG, Y
MAZER, MA
DEWOLF, AM
FUNG, JJ
GASIOR, T
VENKATARAMANAN, R
STARZL, TE
TRANSPLANTATION PROCEEDINGS, 1990, 22 (01) : 21 - 22
[44] NEUROTOXICITY AFTER ORTHOTOPIC LIVER-TRANSPLANTATION - A COMPARISON BETWEEN CYCLOSPORINE AND FK506
MUELLER, AR
PLATZ, KP
BECHSTEIN, WO
SCHATTENFROH, N
STOLTENBURGDIDINGER, G
BLUMHARDT, G
CHRISTE, W
NEUHAUS, P
TRANSPLANTATION, 1994, 58 (02) : 155 - 170
[45] URINARY ENDOTHELIN AND RENAL VASOCONSTRICTION WITH CYCLOSPORINE OR FK506 AFTER LIVER-TRANSPLANTATION
TEXTOR, SC
BURNETT, JC
ROMERO, JC
CANZANELLO, VJ
TALER, SJ
WIESNER, R
PORAYKO, M
KROM, R
GORES, G
HAY, E
KIDNEY INTERNATIONAL, 1995, 47 (05) : 1426 - 1433
[46] SUCCESSFUL ORTHOTOPIC SMALL-BOWEL TRANSPLANTATION WITH SHORT-TERM FK-506 IMMUNOSUPPRESSIVE THERAPY
LEE, KKW
STANGL, MJ
TODO, S
LANGREHR, JM
STARZL, TE
SCHRAUT, WH
TRANSPLANTATION PROCEEDINGS, 1990, 22 (01) : 78 - 79
[47] LONG-TERM INSULIN REQUIREMENT AFTER LIVER-TRANSPLANTATION WITH FK-506 IN AMERICAN VETERANS
TABASCOMINGUILLAN, J
MIELES, L
CARROLL, P
GAVALER, J
VANTHIEL, DH
STARZL, TE
TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 677 - 678
[48] TOXICITY VERSUS REJECTION - OR WHY CONVERSIONS BETWEEN CYCLOSPORINE-A AND FK506 WERE PERFORMED AFTER LIVER-TRANSPLANTATION
PLATZ, KP
MUELLER, AR
JONAS, S
BLUMHARDT, G
BECHSTEIN, WO
LOBECK, H
NEUHAUS, P
CLINICAL TRANSPLANTATION, 1995, 9 (03) : 146 - 154
[49] THE OPTIMAL IMMUNOSUPPRESSANT AFTER LIVER-TRANSPLANTATION ACCORDING TO DIAGNOSIS - CYCLOSPORINE-A OR FK506
MUELLER, AR
PLATZ, KP
BLUMHARDT, G
BECHSTEIN, WO
STEINMULLER, T
CHRISTE, W
HOPF, U
LOBECK, H
NEUHAUS, P
CLINICAL TRANSPLANTATION, 1995, 9 (03) : 176 - 184
[50] EVOLUTION OF CARDIOVASCULAR RISK AFTER LIVER-TRANSPLANTATION - COMPARISON OF CYCLOSPORINE-A AND FK506
CANZANELLO, VJ
SCHWARTZ, L
TALER, SJ
TEXTOR, SC
WIESNER, RH
PORAYKO, MK
KROM, RA
HEPATOLOGY, 1994, 20 (04) : A123 - A123

← 1 2 3 4 5 →